Fixed-Dose Combination of Dipeptidyl Peptidase-4 Inhibitors Plus Metformin in Patients with Type 2 Diabetes: A Review on Safety and Efficacy
Sultan M. Alshahrani, Hamed Ali Alshahrani, Saud Dhafer Alshahrani, Noura Mohammed Alabdulla, Yazeed Fahad Alshahrani, Abdulmohsen Nasser Alshahrani & Ali Mohammed Alshahrani · Journal of Pharmaceutical Research International · 2021
There is a significant increase noted in the incidence and prevalence of Type 2 diabetes mellitus (T2DM). The global number of diabetic patients is projected by the International Diabetes Federation (IDF) to reach 552 million. T2DM disease has chronic and progressive nature. More...
Open access
Research Article
10.9734/jpri/2021/v33i53A33638